J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.R600021-JLR200 on January 2, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
R600021-JLR200v1
48/4/751    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Popa, C.
Right arrow Articles by Stalenhoef, A. F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Popa, C.
Right arrow Articles by Stalenhoef, A. F. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 48, 751-762, April 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology


Review

The role of TNF-{alpha} in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

Calin Popa*,{dagger}, Mihai G. Netea*, Piet L. C. M. van Riel{dagger}, Jos W. M. van der Meer* and Anton F. H. Stalenhoef1,*

* Department of General Internal Medicine, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
{dagger} Department of Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

Published, JLR Papers in Press, January 2, 2007.

1 To whom correspondence should be addressed. e-mail: a.stalenhoef{at}aig.umcn.nl

The recent insight that inflammation contributes to the development of atherosclerosis and type 2 diabetes mellitus constitutes a major breakthrough in understanding the mechanisms underlying these conditions. In addition, it opens the way for new therapeutic approaches that might eventually decrease the prevalence of these public health problems. Tumor necrosis factor-{alpha} (TNF-{alpha}) has been shown to play a key role in these processes and thus might be a potential therapeutic target. Increased concentrations of TNF-{alpha} are found in acute and chronic inflammatory conditions (e.g., trauma, sepsis, infection, rheumatoid arthritis), in which a shift toward a proatherogenic lipid profile and impaired glucose tolerance occurs. Although therapeutic blockade of TNF-{alpha} worsens the prognosis in patients with abscesses and granulomatous infections, this strategy is highly beneficial in the case of chronic inflammatory conditions, including rheumatoid arthritis. Current investigations assessing the impact of anti-TNF agents on intermediary metabolism suggest that TNF-{alpha} blockade may improve insulin resistance and lipid profiles in patients with chronic inflammatory diseases.

Supplementary key words tumor necrosis factor-{alpha} • lipids • anti-tumor necrosis factor • insulin resistance

Abbreviations: apoA-I, apolipoprotein A-I; ATGL, adipocyte triglyceride lipase; CETP, cholesteryl ester transfer protein; CYP7A1, cholesterol-7{alpha}-hydroxylase; DM, diabetes mellitus; HSL, hormone-sensitive lipase; IL-6, interleukin-6; IRS-1, insulin receptor substrate-1; JNK, c-jun-NH2-terminal kinase; LPS, lipopolysaccharide; RA, rheumatoid arthritis; RCT, reverse cholesterol transport; TG, triglyceride; TNF-{alpha}, tumor necrosis factor-{alpha}; TNF-RI, tumor necrosis factor receptor type I


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
S. Egert, S. Wolffram, A. Bosy-Westphal, C. Boesch-Saadatmandi, A. E. Wagner, J. Frank, G. Rimbach, and M. J. Mueller
Daily Quercetin Supplementation Dose-Dependently Increases Plasma Quercetin Concentrations in Healthy Humans
J. Nutr., September 1, 2008; 138(9): 1615 - 1621.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
N. Bartolome, B. Arteta, M. J. Martinez, Y. Chico, and B. Ochoa
Kupffer cell products and interleukin 1? directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes
Innate Immunity, August 1, 2008; 14(4): 255 - 266.
[Abstract] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. G. Kim, J. Y. Kim, M. G. Gim, J. M. Lee, and D. K. Chung
Mechanical stress induces tumor necrosis factor-{alpha} production through Ca2+ release-dependent TLR2 signaling
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C432 - C439.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. L. Oke and K. J. Tracey
From CNI-1493 to the immunological homunculus: physiology of the inflammatory reflex
J. Leukoc. Biol., March 1, 2008; 83(3): 512 - 517.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. Di Comite and C. M. Rossi
Risk of Diabetes in Patients With Rheumatoid Arthritis Taking Hydroxychloroquine
JAMA, November 28, 2007; 298(20): 2368 - 2369.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
C. Popa, F. H J van den Hoogen, T. R D J Radstake, M. G Netea, A. E Eijsbouts, M. d. Heijer, J. W M van der Meer, P. L C M van Riel, A. F H Stalenhoef, and P. Barrera
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis
Ann Rheum Dis, November 1, 2007; 66(11): 1503 - 1507.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.